Announced Thu, 1 Oct, 2026 · 13:36 IST

Concord Drugs 31st AGM: All 7 resolutions passed unanimously

Board & Shareholder Meetings View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.2%Reaction day

₹74.05

prior close

₹74.65

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.3%+3.5% vs market

Pharmaceuticals peers, median of 173sector-0.8%+3.0% vs sector

On the reaction day the stock moved 3.5 pts more than Nifty Microcap 250 and 3.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.7

10m

+1.7

15m

+1.7

30m

+1.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.2-1.3+3.5-0.8+3.0

Next day

+4.0-1.3+5.3-1.3+5.2

-1.4+0.0-1.4-0.4-1.0

-2.1-0.2-1.9-0.1-2.0

-4.1-3.0-1.1-3.0-1.1

-3.7-2.7-1.0-3.1-0.6

-3.0-1.7-1.3-3.1+0.1

15d

-10.9-8.9-2.0-6.9-3.9

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Concord Drugs held its 31st AGM on 30 Sep 2026 via video conference. All 7 resolutions passed with over 99.99 percent approval. Polling covered 48.4 percent of equity shares. Items covered adoption of audited financials, re-appointment of a director and statutory auditors for 5 years, related party transactions for FY26-27, cost auditor pay, and re-appointment of two independent directors.

Likely market impact

All 7 resolutions cleared with overwhelming majority. Routine AGM update with no immediate stock impact.